bioRxivBioengineering
Mechano-Chemo Signaling Interactions Modulate Matrix Production by Cardiac Fibroblasts
J. D. Rogers, J. W. Holmes, J. J. Saucerman, W. J. Richardson
Abstract
Extracellular matrix remodeling after myocardial infarction occurs in a dynamic environment in which local mechanical stresses and biochemical signaling species stimulate the accumulation of collagen-rich scar tissue. It is well-known that cardiac fibroblasts regulate post-infarction matrix turnover by secreting matrix proteins, proteases, and protease inhibitors in response to both biochemical stimuli and mechanical stretch, but how these stimuli act together to dictate cellular responses is still unclear. We developed a screen of cardiac fibroblast-secreted proteins in response to combinations of biochemical agonists and cyclic uniaxial stretch in order to elucidate the relationships between stretch, biochemical signaling, and cardiac matrix turnover. We found that stretch significantly synergized with biochemical agonists to inhibit the secretion of matrix metalloproteinases, with stretch either amplifying protease suppression by individual agonists or antagonizing agonist-driven upregulation of protease expression. Stretch also modulated fibroblast sensitivity towards biochemical agonists by either sensitizing cells towards agonists that suppress protease secretion or de-sensitizing cells towards agonists that upregulate protease secretion. These findings suggest that the mechanical environment can significantly alter fibrosis-related signaling in cardiac fibroblasts, suggesting caution when extrapolating in vitro data to predict effects of fibrosis-related cytokines in situations like myocardial infarction where mechanical stretch occurs.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Fibroblast Mechanotransduction Network Predicts Targets for Mechano-Adaptive Infarct Therapies
Jesse D. Rogers, William J. Richardson·eLifePeer-reviewed·Feb 9, 2022
- Computational Model Predicts Paracrine and Intracellular Drivers of Fibroblast Phenotype After Myocardial Infarction
Angela C. Zeigler, Anders R. Nelson, … Jeffrey J. Saucerman·Matrix BiologyPeer-reviewed·Mar 21, 2020
- Stimulation of cardiac fibroblast Piezo1 channels opposes myofibroblast differentiation and induces IL-6 secretion via Ca2+-mediated p38 MAP kinase activation
N. M. Blythe, V. Stylianidis, … N. A. Turner·bioRxiv·Apr 10, 2019
- Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure
J. M. Amrute, X. Luo, … K. Lavine·bioRxiv·Oct 17, 2022
- Defining the cardiac fibroblast secretome in the healthy and infarcted mouse heart
Jasmin Bahr, Gereon Poschmann, … Jürgen Schrader·Communications BiologyPeer-reviewed·Apr 29, 2025
- An iPSC-derived bio-inspired scaffold modelling the structure and the effects of extracellular matrix in cardiac fibrosis
F. Niro, S. Fernandes, … G. Forte·bioRxiv·Feb 7, 2024